Editorial introductions
Improving the evaluation and diagnosis of clinically significant prostate cancer
Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017
Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging
The role of prostate cancer biomarkers in undiagnosed men
Identification and evaluation of clinically significant prostate cancer
Active surveillance for low-risk prostate cancer
Management of intermediate-risk prostate cancer with active surveillance
Role of MRI in low-risk prostate cancer
Role of MRI prebiopsy in men at risk for prostate cancer
Recent developments of the pelvic floor and lower urinary tract symptoms
Role of chronic exercise on pelvic floor support and function
Female pelvic floor biomechanics
The role of environmental stress on lower urinary tract symptoms
Current treatment of pelvic organ prolapse correlated with chronic pelvic pain, bladder and bowel dysfunction
Female urinary microbiota
Emerging techniques in ‘truly’ minimal-invasive treatment options of benign prostatic obstruction
Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors
Neurogenic voiding dysfunction
Overactive bladder syndrome and lower urinary tract symptoms after prostate cancer treatment